News & Press Releases
Filter by:
11 Mintz Intellectual Property Attorneys Named 2026 IAM Strategy 300 Global Leaders
November 24, 2025
Eleven Mintz attorneys have been featured in the 2026 edition of the Intellectual Asset Management (IAM) Strategy 300 Global Leaders Guide. This annual guide honors professionals whose peers regard their approach to intellectual property as “truly strategic in nature” and who demonstrate a “wealth of expertise across disciplines and sectors,” according to IAM.
Mintz advised the underwriters in connection with Cogent Biosciences, Inc.’s concurrent public offerings of $345 million of common stock (the “Equity Offering”) and $230 million in aggregated principal amount of 1.625% convertible senior notes due 2031 (the “Convertible Notes Offering”).
Mintz Advises on Verastem Oncology’s $103 Million Public Offering
November 21, 2025
Mintz advised the underwriters in connection with Verastem Oncology’s $103 million public offering.
Mintz Advises on Eledon Pharmaceuticals’ $50 Million Follow-on Offering
November 20, 2025
Mintz advised the underwriters in connection with a $50 million follow-on offering by Eledon Pharmaceuticals.
Mintz Advises Diamond Antenna and Microwave Corp. on Acquisition of Antenna Associates
November 20, 2025
Mintz advised Diamond Antenna and Microwave Corporation, a developer of advanced radio frequency and electro-mechanical solutions and a portfolio company of Artemis Capital Partners, on its acquisition of Antenna Associates, a developer of antenna systems for military and commercial applications. This transaction follows Mintz’s representation of Artemis in its 2024 acquisition of Diamond Antenna and Microwave Corporation.
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering
November 20, 2025
Mintz advised the underwriter in connection with a $75 million registered direct offering by Precision BioSciences, Inc.
